Traduction de «€2 53 costs » (Néerlandais → Français) :

TERMINOLOGIE

autosomaal recessieve spastische paraplegie type 53
paraplégie spastique autosomique récessive type 53

Salmonella II, groep O:53
Salmonella II, groupe O:53

humaan adenovirus 53
adénovirus humain 53

humaan rhinovirus 53
rhinovirus humain 53

Salmonella IIIa, groep O:53
Salmonella IIIa, groupe O:53

Salmonella IIIb, groep O:53
Salmonella IIIb, groupe O:53

salmonellagroep O:53
Salmonella groupe O:53

TRADUCTIONS EN CONTEXTE

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

Net sales to third parties 632 632 543 Sales to other divisions 20 20 11 Other revenues 117 117 90 Cost of Goods Sold -432 53 -379 -323 Gross profit 337 53 390 321 Marketing & Sales -86 -86 -57 Research & Development -135 5 -130 -112 General & Administration -32 -32 -39 Other income 1 1 4 Other expense -17 -17 -15 Operating income 68 58 126 102
Eléments de Amortissements restructuration et T3 2010 d’immobilisations Pertes d’intégration liés Eléments T3 2010 T3 2009 Résultats IFRS incorporelles 1 de valeur aux acquisitions exceptionnels Résultats core Résultats core 2 M USD M USD M USD M USD M USD M USD M USD Chiffre d’affaires net réalisé avec des tiers 632 632 543 Chiffre d’affaires réalisé avec d’autres divisions 20 20 11 Autres revenus 117 117 90 Coût des ventes -432 53 -379 -323 Marge brute 337 53 390 321 Marketing et vente -86 -86 -57 Recherche et développement -135 5 -130 -112 Administration et frais généraux -32 -32 -39 Autres produits 1 1 4 Autres charges -17 -17 -15 Résultat opérationnel 68 58 126 102

53. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.
52. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.